Thirteen patients with moderate to severe symptomatic BPH were treated with cetrorelix (5 mg, s.c., twice daily for 2 days followed by 1 mg/day, s.c., for 2 months) and evaluated at baseline, during treatment, and up to 18 months after therapy for effects on the International Prostate Symptom Score (IPSS), Quality of Life score, sexual function, prostate size, uroflowmetry, and hormonal levels
Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression
Pharmacological Reviews 68 (4): 954-1013
For example, PARP inhibitors sensitize ovarian cancer cells to ferroptosis by synergistically activating ATM/ATR and causing DNA damage [126]
W., Anticraving Therapy for Alcohol Use Disorder: A Clinical Review, Neuropsychopharmacology Reports 38, no
1d) and kept the fast plasma insulin level at normal levels (Fig